333 related articles for article (PubMed ID: 30266410)
1. HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas.
Lian Q; Wang S; Zhang G; Wang D; Luo G; Tang J; Chen L; Gu J
Genomics Proteomics Bioinformatics; 2018 Aug; 16(4):269-275. PubMed ID: 30266410
[TBL] [Abstract][Full Text] [Related]
2. HCCDB v2.0: Decompose Expression Variations by Single-cell RNA-seq and Spatial Transcriptomics in HCC.
Jiang Z; Wu Y; Miao Y; Deng K; Yang F; Xu S; Wang Y; You R; Zhang L; Fan Y; Guo W; Lian Q; Chen L; Zhang X; Zheng Y; Gu J
Genomics Proteomics Bioinformatics; 2024 May; 22(1):. PubMed ID: 38886186
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
4. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
[TBL] [Abstract][Full Text] [Related]
5. A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies.
Wang F; Wang R; Li Q; Qu X; Hao Y; Yang J; Zhao H; Wang Q; Li G; Zhang F; Zhang H; Zhou X; Peng X; Bian Y; Xiao W
Diagn Pathol; 2017 Jan; 12(1):4. PubMed ID: 28086821
[TBL] [Abstract][Full Text] [Related]
6. Six genes as potential diagnosis and prognosis biomarkers for hepatocellular carcinoma through data mining.
Zhang Y; Wang Y; Liu H; Li B
J Cell Physiol; 2019 Jun; 234(6):9787-9792. PubMed ID: 30556603
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.
Gong X; Wei W; Chen L; Xia Z; Yu C
Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756
[TBL] [Abstract][Full Text] [Related]
8. Identification of hedgehog signaling as a potential oncogenic driver in an aggressive subclass of human hepatocellular carcinoma: A reanalysis of the TCGA cohort.
Zhao Y; Zhang L; Zhang Y; Meng B; Ying W; Qian X
Sci China Life Sci; 2019 Nov; 62(11):1481-1491. PubMed ID: 31313086
[TBL] [Abstract][Full Text] [Related]
9. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
[TBL] [Abstract][Full Text] [Related]
10. Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.
Zhang L; Liu X; Zhang X; Chen R
Mol Genet Genomics; 2016 Jun; 291(3):1035-51. PubMed ID: 26711644
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
[TBL] [Abstract][Full Text] [Related]
12. Systemic transcriptome analysis of hepatocellular carcinoma.
Yu CB; Zhu LY; Wang YG; Li F; Zhang XY; Dai WJ
Tumour Biol; 2016 Oct; 37(10):13323-13331. PubMed ID: 27460080
[TBL] [Abstract][Full Text] [Related]
13. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
15. Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma.
Zhai X; Xue Q; Liu Q; Guo Y; Chen Z
Mol Med Rep; 2017 Sep; 16(3):3253-3261. PubMed ID: 28713927
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC).
Xu W; Huang H; Yu L; Cao L
Med Oncol; 2015 Apr; 32(4):96. PubMed ID: 25731616
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
Agarwal R; Narayan J; Bhattacharyya A; Saraswat M; Tomar AK
Cancer Genet; 2017 Oct; 216-217():37-51. PubMed ID: 29025594
[TBL] [Abstract][Full Text] [Related]
18. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome sequencing identified hub genes for hepatocellular carcinoma by weighted-gene co-expression analysis.
Pan Q; Long X; Song L; Zhao D; Li X; Li D; Li M; Zhou J; Tang X; Ren H; Ding K
Oncotarget; 2016 Jun; 7(25):38487-38499. PubMed ID: 27220887
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR‑136‑5p in hepatocellular carcinoma and its clinicopathological significance.
Ding H; Ye ZH; Wen DY; Huang XL; Zeng CM; Mo J; Jiang YQ; Li JJ; Cai XY; Yang H; Chen G
Mol Med Rep; 2017 Oct; 16(4):5393-5405. PubMed ID: 28849100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
